IntegriChain’s Post

View organization page for IntegriChain, graphic

74,675 followers

Branded pharmaceutical manufacturers from large to emerging are struggling to ensure patients can find pharmacies that are capable and willing of dispensing Gen Med non-specialty brands, which account for 8% of the prescriptions that flow out of the pharmacy. Home delivery and digital pharmacy have attempted to provide feasible solutions, but to date have been insufficient to address these mounting barriers to access. Join Daniel Landis and Katie Herrick from Blue Fin Group, an IntegriChain Company as they discuss these challenges in Part 1 of our 3 part webinar series on Optimizing Physical Access and Affordability Challenges for Branded Rx Products - Meeting a $35 Patient Out-of-Pocket Target. Register today. https://bit.ly/3W5tzn1

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics